SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
73
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Amyris, Inc. To Contact The Firm

NEW YORK, April 20, 2017 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Amyris, Inc. (“Amyris” or the “Company”) (NASDAQ: AMRS ) of the June 19, 2017 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against the Company and certain officers.

The lawsuit has been filed in the U.S. District Court for the Northern District of California on behalf of all those who purchased Amyris securities between March 2, 2017 and April 17, 2017, (the “Class Period”).  The case, OHREN v. Amyris, Inc. et al., No. 3:17-cv-02210 was filed on April 20, 2017.

The lawsuit focuses on whether the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) the Company made a decision in the first quarter of 2017 to take an equity stake in one of Blue California’s affiliates that focused on the sweetener market in lieu of cash payment under the license agreement; (2) due to the Company’s decision, Amyris would be unable to recognize $10 million in fourth quarter and fiscal year 2016 revenue; and (3) as a result, the Company’s public statements were materially false and misleading at all relevant times.

Specifically, after market close on April 17, 2017, the Company filed a Form 10-K with the Securities and Exchange Commission (“SEC”) reporting, among other things, revenues of $67.2 million for fiscal year 2016. Then, during premarket on April 18, 2017, the Company filed a Form 8-K with the SEC disclosing that the $10 million decrease from the previously reported fiscal year 2016 revenues was due to the Company’s aforementioned decision to take an equity stake in one of Blue California’s affiliates.

As a result of these disclosures, over the course of two trading days the Company’s share price fell from $0.70 per share on April 17, 2017 to a closing price of $0.56 on April 19, 2017—a $0.14 or a 20% drop.

Request more information now by clicking here: www.faruqilaw.com/AMRS . There is no cost or obligation to you.

Take Action

You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com. 

Faruqi & Faruqi, LLP also encourages anyone with information regarding Amyris’ conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class that is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff. 

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( www.faruqilaw.com ). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

FARUQI & FARUQI, LLP 685 Third Avenue, 26th Floor New York, NY 10017 Attn: Richard Gonnello, Esq. rgonnello@faruqilaw.com Telephone: (877) 247-4292 or (212) 983-9330

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 136

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 60

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 637

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 107

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 21

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 208

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 251

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 103

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 49

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 224

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading

Top 5 Most Recently Viewed Articles

Unheard Melody: Song Dynasty Art Bridges Cultures

Updated Category News Views 49

An Artistic Symphony in New York New York City, the melting pot of cultures, just added a dash of Song Dynasty tunes to its already rich artistic repertoire. This ain’t just any art exhibit, folks. We're talking about the North American debut of a centuries-old bonanza of aesthetic delight, coming straight from the heart of China. Brought to life by the China Institute...

Continue Reading
Akamai Revolutionizes Video Streaming with Cloud VPUs

Updated Category News Views 225

Akamai Introduces a Game-Changer in Cloud Computing Akamai has launched a groundbreaking category of cloud-based compute known as Akamai Cloud Accelerated Compute Instances, powered by NETINT video processing units (VPUs). This innovative service marks a significant step forward in cloud computing, designed specifically for tasks that require efficient video processing...

Continue Reading
Exploring the Future of the Fan Coil Unit Market Growth

Updated Category News Views 56

Growth Projections for the Fan Coil Unit Market The fan coil unit market is expected to achieve remarkable growth, reaching an estimated USD 7.16 billion in the coming years. This positive outlook is driven by several factors, including advancements in technology and an increasing focus on energy efficiency across various sectors. Technological Advancements in Fan Coil...

Continue Reading
Shell plc Reports Significant Share Buy-Back Activities

Updated Category News Views 179

Overview of Share Buy-Back Activities Shell plc recently made headlines with its strategic share buy-back program aimed at enhancing shareholder value. This initiative highlights the Company’s commitment to return equity to investors while managing its financial resources effectively. Details of Recent Share Transactions On a notable date, the Company purchased a total...

Continue Reading
FCP Enhances Investment Strategy with Latest Apartment Acquisition

Updated Category News Views 281

FCP Enhances Investment Strategy with Latest Apartment Acquisition FCP is excited to announce the acquisition of Alexan Miramar Apartments, a recently completed multifamily community featuring 250 units. This property is strategically located, enhancing FCP's portfolio in vibrant residential markets. About the Alexan Miramar Community Alexan Miramar offers an array of...

Continue Reading